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Qualitative analysis of a new web-based system for mon-
itoring and evaluation of HIV/AIDS, El Salvador 2009
M. Mengel1,∗, J. Armero2, F. Job1
1 Instituto Carlos III, Madrid, Spain
2 Minstry of Public Health and Social Assistance, San Sal-
vador, El Salvador
Background: In February 2009, the Ministry of Health
(MoH) of El Salvador launched SUMEVE, a unitary web-based
system for monitoring and evaluation of HIV/AIDS. SUMEVE
collects data on every person seeking testing or treatment
for HIV/AIDS. In May 2009 we performed an early, qualita-
tive analysis to verify whether the system was operating as
designed.
Methods: We selected a convenience sample of 5/30
collection centres and 6/30 laboratories at regional and
central level and performed a qualitative analysis assess-
ing the system’s resources and functioning, following
CDC (Atlanta)’s ‘‘Updated Guidelines for Evaluating Pub-
lic Health Surveillance Systems’’. Standardized interviews
with SUMEVE-professionals were conducted to explore the
system’s strengths, weaknesses, opportunities and threats
(SWOT-format).
Results: Patient data are entered on paper forms when
HIV rapid testing is requested at primary health-care facil-
ities and forwarded with the HIV test results to the
collection-centres for entry into the online database.
97% of primary health care facilities and 100% of HIV labo-
ratories are reporting to SUMEVE, producing exhaustive data
and showing wide system acceptability. Timeliness varies 1-
7 days between generating and digitizing notiﬁcation forms
for instant analysis.
SWOT analysis shows as strengths a comprehensive legal
framework for SUMEVEwhich is part of the National HIV/AIDS
plan. Registration by name avoids double notiﬁcation.
Results are regularly published on MoH website.
Data conﬁdentiality is guaranteed by password-restricted
access.
The system has a ﬂexible modular design allowing to
amend and remove indicators.
Identiﬁed weaknesses were: lacking reliable internet
connection at two of the centres and that notiﬁcation forms
there could not be stored conﬁdentially.
As opportunities, we identiﬁed advocating renewed polit-
ical commitment of the current government to guarantee
the stability of SUMEVE and take actions in beneﬁt of vul-
nerable groups identiﬁed by SUMEVE.
No current threats to the system performance could be
identiﬁed.
Conclusion: SUMEVE is operating as planned on all levels,
collecting exhaustive data of at least 97% of primary health
care facilities. Identiﬁed weaknesses are being improved.
SUMEVE is the only surveillance system to direct public
health interventions for HIV/AIDS. We recommend perform-
ing a re-evaluation after one year to assess the value of the
SUMEVE for planning and executing intervention measures.
doi:10.1016/j.ijid.2010.02.1655
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IV infection in elderly (patients over 65 years)
. Almasi Nokiani
University Paris 6, Courbevoie, France
Background: After 1996 with highly active antiretroviral
herapy, not only HIV infected people live longer but also
ew HIV infection occurs in older people.
Methods: This is a Retrospective observational study in
egistered HIV infected patients older than 65 years old in
rder to review special epidemiologic, clinical and biologic
spects of HIV infection in elderly.
Results: Among 1680 registered HIV infected patients in
his center, there are 61 HIV infected patients older than 65
ears old including 13 women (21%) and 48 men (79%). The
ldest patient is an 84 years old man and male-female ratio
s 4/1. There are 29 homosexualbisexual transmission (47%),
4 heterosexual transmission (40%), only one patient blood
ransmission and 7 patients who denied any risk factors
11%). 23 patients (38%) are coming with AIDS deﬁning con-
ition (stage C), 13 patients (21%) are symptomatic (stage
) and 25 patients (41%) are asymptomatic (stage A). Before
ntiretroviral treatment, CD4 count was between 9 and 493
s a mean 231cell/ml. There were 24 patients (40%) with
D4 count less than 200 and 7 patients (11%) with CD4 count
ess than 100 cells/ml. Recent CD4 count, was between10
nd 1080 and as a mean 478. There is an important increase
n CD4 count (247 cells/ml) after antiretroviral treatment.
iral load before treatment was ranged between 6410 to
740000 copies/ml. Mean viral load was 230184. There are
nly 5 untreated patients (8%). After antiretroviral treat-
ent 8 patients present viral load more than 500 copies/ml
ncluding 2 untreated patients. It means 6 patients (10%)
uffered from conﬁrmed virologic failure and 7 patients
11%) present detectable viral load but less than 500
opies.
Conclusion: 80% of HIV infected people older than 65 are
en. Homosexual contact is the major risk factor in this
roup. In spite of 40% asymptomatic patients there are near
0% stage C. 40% of patients were coming with low CD4 count
less than 200). Mean CD4 count before treatment was 231
hich is less than younger HIV infected patients, may be
ecause of low CD4 count in older patients and/or late diag-
osis of HIV infection in elderly. Virologic response is as well
s younger patients even better.
oi:10.1016/j.ijid.2010.02.1656
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rimary human immunodeﬁciency virus-1 infection: Clin-
cal, virological and immunological characteristics of a
raziliam cohort
. Pellegrino ∗, E. Boccardo, M. Eira, R. Silva, I. Moreira, M.
ocoli Rossi
Institute of Infectious Diseases Emilio Ribas, Sao Paulo,
razil
Background: Primary HIV-1 infection (PHI) consists in the
eriod of time between viral acquisition and seroconver-
ion, its hallmark is high viremia and consequently increased
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nfectiousness. The occurrence, severity and duration of
ymptoms are predictive factors of clinical deterioration.
e report here the epidemiological, clinical, virological and
mmunological characteristics of a cohort of patients with
HI.
Methods: Prospective observational study of patients
ith PHI at the Emilio Ribas Institute of Infectious Dis-
ases, a tertiary hospital in Sao Paulo, Brazil. Inclusion
riteria included negative or undetermined HIV-1 serology
ssociated with viral detection, or clinical and serological
vidence of seroconversion during the last 6 months. Epi-
emiological history, clinical data, HIV-1 plasma viral load,
D4 cell count, genotypic resistance testing, serology for
epatitis B, C, A, toxoplasmosis, cytomegalovirus, herpes
nd syphilis were recorded as well as the use of highly active
ntiretroviral treatment (HAART).
Results: Between 2007 and 2009, 10 patients met the
nclusion criteria (8 males and 2 females, median age
as 34). Two patients were asymptomatic and eight were
ymptomatic. The main symptoms were fever (80%), myal-
ia (60%), rash (30%), hepatitis (20%) aseptic meningitis
20%) and renal failure (10%). Only 4 patients had a
ononucleosis-like illness. Homosexual transmission route
as more frequent (60%). Five patients had plasma viral
oad above the upper limit of detection and the median
D4 cell count was 395cel/mm+ (range: 47—835cel/mm+).
ive patients received HAART and among 5 patients who
id not receive HAART, 2 patients had clinical and immuno-
ogical criteria for initiating HAART after 12 months of
ollow-up. Genotypic resistance testing was available for 4
atients. Overall patients had triple class susceptible HIV-
sub-type B strain. One patient had primary resistance to
on-nucleoside reverse transcriptase inhibitors and several
rotease inhibitors mutations and this ﬁnding was correlated
ith clinical severity.
Conclusion: Clinical, virological and immunological
arameters in PHI may be heterogenous, atypical clinical
resentation is frequent. Determinating resistance proﬁle is
seful for early therapeutic intervention, which is associated
ith better outcome.
oi:10.1016/j.ijid.2010.02.1657
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revalence of metabolic syndrome and estimated Fram-
ngham risk score among Brazilian HIV-infected patients
. Margareth1,∗, E.L. Dorea2, I.M. Bensenor3, I.R.S.
liveira2, G.A. Pinto2, A.L. Sassaki 2, P.A. Lotufo3
Instituto de Infectologia Emílio Ribas, Sao Paulo, Brazil
Hospital Universitário, University of Sao Paulo, Sao Paulo,
razil
Faculdade de Medicina, University of Sao Paulo, Sao Paulo,
razil
Background: Recent studies suggest that HIV infection
tself or combination ART (cART) were both associated with
ncreased risk for cardiovascular disease (CVD). The 10-year
ramingham risk score (FRS) is used to predict cardiovascular
vents in the non-HIV-infected patients, and its applica-
ion in the HIV-infected subjects is under discussion. We
valuated the traditional CVD risk factors and metabolic
s
g
s
aternational Congress on Infectious Diseases (ICID) Abstracts
yndrome (MS) components among HIVinfected patients ART-
reated and ART-naïve.
Methods: This was a cross-sectional study of HIV-infected
ubjects ART-treated (n = 29), HIVinfected patients ART-
aive (n = 28) and controls without previous CVD events
n = 32). Subjects were selected for common age range
20 to 69 years) from the Instituto de Infectologia Emilio
ibas, São Paulo. We assessed cardiovascular risk factors,
IV viral load, nadir CD4 count, high-sensivity C-reactive
rotein (hs-CRP) and plasma lipid concentrations. MS compo-
ents included low LDL cholesterol, high triglycerides, high
MI, hypertension and diabetes. The statistical analysis were
one using a SPSS 16.0.
Results: Groups were matched for age (mean 43.6 years
or ART-treated vs 42.0 years for ART-naïve vs 42.8 for con-
rols); 31%, 35.7% o and 46.8% are women, respectively.
he mean duration of HIV infection was 10 years for ART-
reated and 6 years for ART-naïve subjects. The mean nadir
D4 count (cells/L) was 208 for ART-treated and 449
or ARTnaïve subjects (p < 0.0001); current HIV-RNA levels
ere undetectable on ART-treated and 13.683 copies/ml on
RT-naïve subjects (p = 0.005). There were no signiﬁcant dif-
erences between the groups in levels of hs-CRP, HDL and
DL-cholesterol. Total cholesterol was higher in ART-treated
han in ART-naïve (mean 209 vs 182mg/dl, respectively;
= 0.02); triglycerides was higher in ART-treated than in
RT-naïve subjects (mean 234 vs 137mg/dl, respectively;
= 0.02). Hypertension was more frequent in ART-treated
ompared to the others groups (p = 0.01). 41.4% of ART-
reated patients had MS, compared to 25% of ARTnaïve and
8.1% of controls (p = 0.0001); 27.6% of ART-treated had a
igh (> 20%) 10-year FRS compared to 0% in the others groups
p < 0.0001).
Conclusion: Our results shows a high prevalence of MS
nd high FRS in HIV-patients under treatment, which can
e used to predict cardiovascular risk stratiﬁcation in this
opulation.
oi:10.1016/j.ijid.2010.02.1658
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actors affecting acceptance of HIV testing among ante-
atal care attendees in Ethiopia: With emphasis on role
f male partners
. Zewde
EngenderHealth, Hawassa, Ethiopia
Background: Counselling and testing is an entry point for
MTCT of HIV infection. To increase uptake of PMTCT inter-
entions and to beneﬁt more generally from HIV testing, the
reater involvement of men is important. This study was
esigned to assess factors affecting acceptance of HIV test-
ng among antenatal care (ANC) attendees with emphasis on
ole of male partners, in Wolaita zone, southern Ethiopia.
Methods: Cross-sectional study was conducted on 412
regnant women using structured questionnaire from March
o April 2008 in three public health centers of Wolaita zone,
outhern Ethiopia. The study was complimented and trian-
ulated by focus group discussions (FGDs). In the absence of
imilar study, the sample size was determined based on the
ssumption that 50% of women would make joint (with their
